EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer

Samantha Gogola iD, Michael Rejzer iD, Hisham F Bahmad iD, Ferial Alloush, Yumna Omarzai, Robert Poppiti

Cancers · 06.03.2023 · 15 (5) · 1621

DOI: 10.3390/cancers15051621 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 06.03.2023. Verfasst von Samantha Gogola und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is the second-most commonly diagnosed cancer in men around the world. It is treated using a risk stratification approach in accordance with the National Comprehensive Cancer Network (NCCN) in the United States. The main treatment options for early PCa include external beam radiation therapy (EBRT), brachytherapy, radical prostatectomy, active surveillance, or a combination approach. In those with advanced disease, androgen deprivation therapy (ADT) is considered as a first-line therapy. However, the majority of cases eventually progress while receiving ADT, leading to castration-resistant prostate cancer (CRPC). The near inevitable progression to CRPC has spurred the recent development of many novel medical treatments using targeted therapies. In this review, we outline the current landscape of stem-cell-targeted therapies for PCa, summarize their mechanisms of action, and discuss avenues of future development.

Schlagwörter

Stichwörter der Autor:innen

cancer stem cellsprostate cancertargeted therapytherapy resistance

Autor:innen und Institutionen

  • Department of Translational Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
  • The Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.

ORCID-Profile: Samantha Gogola, Michael Rejzer, Hisham F Bahmad

Zitieren

APA

Gogola, S., Rejzer, M., Bahmad, H. F., Alloush, F., Omarzai, Y., & Poppiti, R. (2023). Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer. Cancers, 15(5), 1621. https://doi.org/10.3390/cancers15051621

Vancouver

Gogola S, Rejzer M, Bahmad HF, Alloush F, Omarzai Y, Poppiti R. Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer. Cancers. 2023;15(5):1621. doi:10.3390/cancers15051621

BibTeX
@article{Gogola2023,
  author = {Gogola, Samantha and Rejzer, Michael and Bahmad, Hisham F and Alloush, Ferial and Omarzai, Yumna and Poppiti, Robert},
  title = {Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {5},
  pages = {1621},
  doi = {10.3390/cancers15051621}
}
Kostenlos starten →